Enhancement of drug therapy by miRNA

Details for Australian Patent Application No. 2009244267 (hide)

Owner Abraxis BioScience, LLC

Inventors Desai, Neil; Hwang, Larn; Trieu, Vuong

Agent Pizzeys

Pub. Number AU-A-2009244267

PCT Pub. Number WO2009/137660

Priority 61/051,309 07.05.08 US

Filing date 7 May 2009

Wipo publication date 12 November 2009

International Classifications

A61K 31/00 (2006.01)

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137660 Priority application(s): WO2009/137660

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244268-Analyte measurement and management device and associated methods

2009244265-Compositions comprising 2,3-dichloro-1,1,1-trifluoropropane, 2-chloro-1,1,1-trifluoropropene, 2-chloro-1,1,1,2-tetrafluoropropane or 2,3,3,3-tetrafluoropropene